Gary Taylor

Stock Analyst at TD Cowen

(2.00)
# 3,130
Out of 5,091 analysts
148
Total ratings
50.51%
Success rate
-0.28%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $14.00
Upside: +78.57%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $19.65
Upside: +113.74%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $5.10
Upside: +145.10%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $0.69
Upside: +188.14%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $256.39
Upside: +4.53%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $19.36
Upside: -32.85%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $485.15
Upside: -9.31%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $323.62
Upside: +88.18%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $37.88
Upside: +134.95%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $155.51
Upside: +143.07%
Maintains: Hold
Price Target: $183$220
Current: $226.13
Upside: -2.71%
Maintains: Hold
Price Target: $139$150
Current: $117.05
Upside: +28.15%
Maintains: Outperform
Price Target: $30$26
Current: $23.63
Upside: +10.03%
Upgrades: Outperform
Price Target: $39$35
Current: $16.72
Upside: +109.33%
Maintains: Outperform
Price Target: $564$585
Current: $330.61
Upside: +76.95%
Maintains: Market Perform
Price Target: $3$6
Current: $16.73
Upside: -64.14%
Maintains: Outperform
Price Target: $10$8
Current: $6.41
Upside: +24.80%
Upgrades: Outperform
Price Target: $242$329
Current: $263.54
Upside: +24.84%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.56
Upside: +17.19%
Initiates: Market Perform
Price Target: $17
Current: $4.79
Upside: +254.91%
Downgrades: Underweight
Price Target: $28$20
Current: $206.31
Upside: -90.31%
Maintains: Neutral
Price Target: $33$20
Current: $21.57
Upside: -7.28%
Downgrades: Underweight
Price Target: n/a
Current: $3.32
Upside: -